EGFR and non-small cell lung carcinoma: Previous studies of the rs884225 SNP in exon 28 of the EGFR gene have shown that the rs884225 SNP is associated with the risk of developing Adverse reaction (ADR) in TKIs-treated patients with advanced NSCLC in the Chinese population (Winther-Larsen et al., 2019).